Solving the hypomyelination conundrum - Imaging perspectives

Prateek Malik1, Karthik Muthusamy1, Kshitij Mankad2

  • 1Christian Medical College, Vellore, India.

Insights

Hypomyelinating leukodystrophies (HLDs) are brain disorders identified by MRI. This review details myelination neurobiology and offers a diagnostic algorithm for HLDs based on imaging patterns.

Area of Science:

  • Neuroscience
  • Genetics
  • Radiology

Background:

  • Hypomyelinating leukodystrophies (HLDs) represent a significant group of undiagnosed genetic brain disorders.
  • A common feature of HLDs is a deficit of myelin, detectable via Magnetic Resonance (MR) imaging.
  • The MR imaging phenotype is crucial for raising diagnostic suspicion and guiding genetic testing.

Purpose of the Study:

  • To review the neurobiology of myelination, emphasizing the intricate molecular genetic pathways involved.
  • To present a practical diagnostic algorithm for common hypomyelinating disorders, integrating clinical and radiological findings.
  • To discuss current definitions and the application of the term 'hypomyelination'.

Main Methods:

  • Review of neurobiology of myelination and molecular genetic pathways.
  • Development of a clinico-radiological diagnostic algorithm based on neuroimaging patterns.
  • Analysis of current literature and controversies regarding the definition of 'hypomyelination'.

Main Results:

  • HLDs are characterized by a unifying MR imaging appearance of myelin deficit.
  • The MRI phenotype is a key diagnostic clue for HLDs.
  • A practical diagnostic algorithm integrating clinical, radiological, and genetic data is proposed.

Conclusions:

  • HLDs are a major category of leukodystrophies, often diagnosed through characteristic MRI findings.
  • Understanding myelination pathways is essential for diagnosing and managing HLDs.
  • A structured diagnostic approach aids in identifying specific hypomyelinating disorders.

Related Concept Videos